S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

Chardan Healthcare Acquisition 2 Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
+0.10 (+1.16%)
(As of 11/26/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
10,151 shs
Average Volume
55,653 shs
Market Capitalization
$94.31 million
P/E Ratio
Dividend Yield

Receive CHAQ News and Ratings via Email

Sign-up to receive the latest news and ratings for Chardan Healthcare Acquisition 2 and its competitors with MarketBeat's FREE daily newsletter.

Chardan Healthcare Acquisition 2 logo

About Chardan Healthcare Acquisition 2

Chardan Healthcare Acquisition 2 Corp. does not have significant operations. It intends to acquire assets and businesses through a merger, share exchange, stock purchase, recapitalization, reorganization, or other similar business combination. The company was incorporated in 2018 and is based in New York, New York.


Renovacor Inc
October 1, 2021 |  reuters.com
See More Headlines

Industry, Sector and Symbol

Biological products, except diagnostic
Year Founded

Sales & Book Value

Annual Sales
Book Value
($0.54) per share


Net Income
$-780 thousand
Pretax Margin




Free Float
Market Cap
$94.31 million
Not Optionable


Overall MarketRank

0.17 out of 5 stars

Medical Sector

1360th out of 1,391 stocks

Biological Products, Except Diagnostic Industry

199th out of 201 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -

Chardan Healthcare Acquisition 2 (NYSE:CHAQ) Frequently Asked Questions

Who are Chardan Healthcare Acquisition 2's key executives?

Chardan Healthcare Acquisition 2's management team includes the following people:
  • Dr. Gbolahan Amusa C.F.A., M.D., CFA, Chief Science Officer & Exec. Chairman (Age 46)
  • Mr. Jonas Sven Magnus Grossman, Pres, CEO & Director (Age 47)
  • Mr. George B. Kaufman B.A., CFO, Head of Strategy & Director (Age 46)
  • Mr. Guy Barudin, Chief Operating Officer (Age 60)

What is Chardan Healthcare Acquisition 2's stock symbol?

Chardan Healthcare Acquisition 2 trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHAQ."

What is Chardan Healthcare Acquisition 2's stock price today?

One share of CHAQ stock can currently be purchased for approximately $8.75.

How much money does Chardan Healthcare Acquisition 2 make?

Chardan Healthcare Acquisition 2 has a market capitalization of $94.31 million.

How many employees does Chardan Healthcare Acquisition 2 have?

Chardan Healthcare Acquisition 2 employs 2 workers across the globe.

What is Chardan Healthcare Acquisition 2's official website?

The official website for Chardan Healthcare Acquisition 2 is www.chardanhealthcarespac.com.

Where are Chardan Healthcare Acquisition 2's headquarters?

Chardan Healthcare Acquisition 2 is headquartered at 17 STATE STREET 21 FLOOR, NEW YORK NY, 10004.

How can I contact Chardan Healthcare Acquisition 2?

Chardan Healthcare Acquisition 2's mailing address is 17 STATE STREET 21 FLOOR, NEW YORK NY, 10004. The company can be reached via phone at 646-465-9000.

This page was last updated on 11/28/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.